Objective:

To clarify misconceptions regarding the use of phthalates in softgel capsules and their associated health risks, particularly in media narratives.

Key Findings:

• No phthalates are used as plasticizers in softgel capsules manufactured by Catalent.
• Phthalates are primarily found in tablets and powder-filled capsules, not softgels.
• Low molecular weight (LMW) phthalates are approved for use in some medicinal products but are not linked to the same health risks as high molecular weight (HMW) phthalates.
• There is no evidence supporting the presence of phthalates in softgel capsules across the market.

Interpretation:

The claims linking softgel capsules to phthalate-related health risks are unfounded, as evidence does not support the presence of phthalates in these products.

Limitations:

• The article does not account for all softgel products on the market, particularly those not manufactured by Catalent.
• Potential existence of softgel capsules with LMW phthalate coatings is acknowledged but not substantiated, and a comprehensive market analysis is lacking.

Conclusion:

Softgel capsules are safe and do not pose a significant risk of early death due to phthalate exposure, as there is no evidence supporting such claims.